COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation...

Psychedelic Bulletin #138: Delix’s Non-Hallucinogenic Psychedelic Enters the Clinic; Arizona Earmarks...

Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21

PT412 – Psychedelics and Virtual Reality: Where Novel Experience, Technology, and...

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part...

FILAMENT HEALTH ANNOUNCES INTERIM RESULTS FROM PHASE I CLINICAL TRIAL AT...

COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference

Psychedelics Weekly – New LSD Research and The Challenges Facing a...

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and...

Sunstone Therapies presents data at ASCO showing positive long-term follow-up results...

Load more